Results 11 to 20 of about 291,166 (259)
Molecular Oncology, 2023 The identification of the high‐efficiency and non‐invasive biomarkers for hepatocellular carcinoma (HCC) detection is urgently needed. This study aims to screen out potential autoantibodies to tumor‐associated antigens (TAAbs) and to assess their ...
Qian Yang +9 more
doaj +1 more source
Adenocarcinosarcoma at the esophagogastric junction with long esophageal invasion: a case report
Surgical Case Reports, 2020 Background Carcinosarcoma of the esophagus or esophagogastric junction (EGJ) is a rare malignancy with both carcinomatous and sarcomatous components.
Kenichiro Furukawa +4 more
doaj +1 more source
Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran [PDF]
, 2009 We evaluated the effect of NQO1 genetic variation on PAH-DNA adducts in esophageal squamous cell carcinoma (ESCC) in northeast Iran. Golestan Province in northeast of Iran has one of the highest esophageal cancer incidences in the world.
Biramijamal, F. +4 more
core +3 more sources
Frontiers in Oncology, 2023 BackgroundThe impact of hospital volume on the long-term survival of esophageal squamous cell carcinoma (ESCC) has not been well assessed in China, especially for stage I–III stage ESCC.
Ling-Ling Lei +26 more
doaj +1 more source
Surgical Case Reports, 2019 Background Non-occlusive mesenteric ischemia (NOMI) is a rare but life-threatening complication of early postoperative enteral feeding. We herein report two patients who developed NOMI during enteral feeding after esophagectomy. Case presentation In case
Daisuke Kurita +5 more
doaj +1 more source
Nature Communications, 2021 The benefit of induction chemotherapy before definitive chemoradiotherapy (CRT) for patients with esophageal cancer is still uncertain. The results of this phase II randomized trial show that the addition of induction chemotherapy to CRT does not improve
Shiliang Liu +13 more
doaj +1 more source
T2N0M0 esophageal cancer [PDF]
The Journal of Thoracic and Cardiovascular Surgery, 2007 The study objective was to develop a treatment algorithm for cT2N0M0 esophageal cancer by determining (1) errors in clinical staging and (2) consequences of overtreatment and undertreatment of incorrectly clinically staged patients.Of 742 clinically staged patients, 61 (8.2%) had cT2N0M0 cancer; 45 underwent surgery alone; 8 underwent surgery and ...
Lisa Rybicki +6 more
openaire +3 more sources
Surgical Case Reports, 2022 Background Anastomotic stenosis can occur after esophagectomy and gastric tube reconstruction. The effective surgical treatment for refractory anastomotic stenosis, which seems difficult to resolve with endoscopic treatment, has not been established.
Kazuya Yamaguchi +4 more
doaj +1 more source
Radiochemotherapy of Esophageal Cancer [PDF]
Journal of Thoracic Oncology, 2007 Cancer of the esophagus continues to be a threat to public health. The common practice is esophagectomy for surgically resectable tumors and radiochemotherapy for locally advanced, unresectable tumors. However, local regional tumor control and overall survival of esophageal cancer patients after the standard therapies remain poor, approximately 30% of ...
R.U. Komaki +2 more
openaire +3 more sources
Discover Oncology, 2023 Background Esophageal squamous cell carcinoma (ESCC) is the most common esophageal malignancy, and RNA methylation has been reported to be involved in the tumorigenesis of ESCC.
Ruixi Wang +6 more
doaj +1 more source